View More Recent Stories

Jun 14, 2024 06:54AM UroGen Pharma (URGN) PT Raised to $53.50 at Ladenburg Thalmann
Jun 14, 2024 06:35AM UroGen Pharma (URGN) PT Raised to $60 at H.C. Wainwright
Jun 14, 2024 05:11AM Goldman Sachs Reiterates Neutral Rating on UroGen Pharma (URGN)
Jun 13, 2024 02:21PM TD Cowen Reiterates Buy Rating on UroGen Pharma (URGN)
Jun 13, 2024 10:56AM UroGen Pharma (URGN) option IV into data
Jun 13, 2024 10:45AM UroGen (URGN) Announces 82.3% Duration of Response at 12 Months in ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
Jun 13, 2024 10:40AM UroGen Pharma (URGN) Halted, News Pending
View More Recent Stories